CSS
RMTI icon

Cubist Systematic Strategies’s Rockwell Medical RMTI Stock Holding History

Cubist Systematic Strategies’s Portfolio RMTI Stock Details RMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,722
Closed -$227K – 3478
2024
Q3 		$227K Buy
+5,722
New +$154K ﹤0.01% 2529

Other funds holding RMTI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Cubist Systematic Strategies's RMTI Position: Q4 2024 in Review

Cubist Systematic Strategies sold out of Rockwell Medical (RMTI) in Q4 2024, closing a stake of 5,722 shares — an estimated $227K sold.

Cubist Systematic Strategies first reported a position in RMTI in Q3 2024 and held it in 1 quarter. The position peaked at $227K in Q3 2024. 53 funds tracked by Wall St. Rank hold RMTI as of Q4 2024.

  • Cubist Systematic Strategies reported no remaining Rockwell Medical position as of Q4 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 5,722 Rockwell Medical shares in Q4 2024, an estimated $227K.
  • Cubist Systematic Strategies first reported a position in Rockwell Medical in Q3 2024 and held it in 1 quarter.
  • Cubist Systematic Strategies's Rockwell Medical position peaked at $227K in Q3 2024.
  • 53 funds tracked by Wall St. Rank held Rockwell Medical as of Q4 2024.

Based on Cubist Systematic Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.